← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Tocagen, Inc.
San Diego, CA
$1,769,025
Total funding
2
Grants
Funding over time
peak $500K · FY2012–19$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
FDA$1,500,000 · 1
NIH$269,025 · 1
By mechanism
R01$1,500,000 · 1
R43$269,025 · 1
Investigators at Tocagen, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Phase 2/3 Study of Toca 511-Toca FC vs SOC in Recurrent GBM-AA IND 14173 9Jul2015$500,000
R01 · FY2018 · FD
Phase 2/3 Study of Toca 511-Toca FC vs SOC in Recurrent GBM-AA IND 14173 9Jul2015$500,000
R01 · FY2019 · FD
Phase 2/3 Study of Toca 511-Toca FC vs SOC in Recurrent GBM-AA IND 14173 9Jul2015$500,000
R01 · FY2017 · FD
Retroviral replicating vector for prodrug activator gene therapy$269,025
R43 · FY2012 · CA